Clinical Trial Update: Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase I trial evaluating ganetespib with capecitabine and radiation in rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Ganetespib (ganetespib)

Snippet

Sponsor: Emory University | Conditions: Rectal Cancer | Phase 1 | Status: COMPLETED